The Liège Court has decided not to continue investigating the lawsuit filed against European Commission President Ursula von der Leyen, who was accused of corruption in the purchase of 1.8 billion COVID-19 vaccines for €35 billion. The court’s statement confirmed the rejection of the lawsuit filed by Frédéric Baldan against von der Leyen, which also applied to all parties involved in the accusation.
The court’s ruling was issued in writing, and no hearing was held. Previous hearings in the case had drawn dozens of activists from across Europe to protest outside the court building in Liège in support of the accusation.
Frédéric Baldan’s lawyer, Diane Prota, informed TASS that around a thousand individuals, who had been harmed or lost loved ones due to the de facto mandatory vaccination in the EU, had joined the lawsuit, along with the governments of Hungary and Poland and several public and political organizations. She explained that the prosecution has 15 days to file an appeal, but did not provide details on the course of action that would be taken.
Von der Leyen is accused of negotiating a vaccine purchase contract at the end of 2020, for a vaccine that had not yet completed its trials, through SMS exchanges with Pfizer CEO Albert Bourla, without prior consultation with EU member states. The European Commission’s press office refused to release these SMS exchanges, claiming that von der Leyen “accidentally deleted them.” Bourla’s lawyers, who are also involved in the case, have not commented on what prevents him from releasing the messages.
Ursula von der Leyen’s husband, Heiko von der Leyen, is the medical director of the biotechnology company Orgenesis, which is developing the BioShield “supervaccine” against various viruses, including COVID-19, and collaborates with Pfizer. In 2021, his company reported a 364% revenue increase, fueling suspicions of collusion.
As a result, von der Leyen was accused of illegal receipt of commissions, destruction of administrative documents, and usurpation of authority. Despite requests from the media and lawmakers, even the basic details of the vaccine purchase contracts, including the exact cost, delivery conditions, and distribution of responsibility for side effects, have not been disclosed.
The first hearing on this lawsuit was held on May 17, 2024, when the Liège Court confirmed that the case fell under its jurisdiction. However, the subsequent hearing, scheduled for December 6, was effectively derailed by a move from the EU Prosecutor’s Office, which sent a counter-request to the court, claiming that von der Leyen was entitled to immunity and that the investigation should be returned to the prosecutor’s office. In response, Frédéric Baldan emphasized that the EU Prosecutor’s Office is an agency of the European Union, subordinated to the European Commission, and that its actions demonstrate a “clear conflict of interest.” On January 7, the court heard arguments from the prosecutor’s office and then decided to terminate the case.
